Download hemorrhage-case-studies_in

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Jehovah's Witnesses and blood transfusions wikipedia , lookup

Obstetrics wikipedia , lookup

Transcript
Postpartum Hemorrhage Case Study
Providence Clinical Academy: Obstetrics Curriculum
What risk factors for PPH do you see in this case? Choose all
that apply.
a)
Low platelets
b)
Prolonged second stage of labor
c)
Use of prolonged oxytocin during the induction
d)
Epidural anesthesia
e)
History of preeclampsia
f)
Operative vaginal delivery
2
Knowledge Check
JoAnn,
a 25-year-old
G1P0,
The labor
epidural is placed
at is
5
cm induced
of dilation.with
The prolonged
physician uses
oxytocin
at aterm
for mild
low
forceps for
prolonged
(5 hr)
preeclampsia.
Her
admission
second stage and delivers a 9 lb
hematocrit
is 39% and
her
baby.
After an uneventful
delivery
platelet
count isheavy
190,000/µL.
of the placenta,
vaginal
Systolic
bleeding blood
ensues.pressure
Inspectionranged
of the
from
154 reveals
to 142 no
mmHg
and
placenta
missing
diastolic
blood
pressureoffrom
cotyledons
and inspection
the
98
to
88
mmHg
prior
to
lower genital tract reveals no
admission
during
labor.
lacerations orand
source
of bleeding.
Palpation of the uterus reveals
severe atony.
Providence Clinical Academy: Obstetrics
2016.07
What medication should be ordered by physician at this point?
Knowledge Check
a)
Oxytocin IV push
b)
Methergine 2 mg IM
c)
Hemabate (carboprost) 0.25 mg IV
d)
3
Bimanual massage is initiated
by the physician and IV
oxytocin is infusing at a rapid
rate. There is no immediate
improvement in uterine tone.
Current vital signs are: BP
130/75 mmHg
P 96 bpm.
Cytotec (misoprostol) 800
Providence Clinical Academy: Obstetrics
2016.07
Which of the following interventions would not be appropriate
for JoAnn at this time? Choose all that apply.
a)
Vital signs and uterine assessment to q 5 minutes
b)
Weighing pads to accurately assess blood loss
c)
Bimanual fundal massage
d)
STAT laboratory testing such as CBC, PT, PTT,
fibrinogen
Knowledge Check
Cytotec is administered and
uterus remains atonic. The EBL
is 800 mL during the delivery
and another 700 mL.
Hemabate is ordered and
administered.
Current vital signs:
BP 119/69 mmHg
P 108 bpm
e)
Order OB Hemorrhage Pack
f)
Continue to monitor patient status in the room
4
Providence Clinical Academy: Obstetrics
2016.07
Intervention & Management: Algorithm
STAGE 1
Cumulative Blood Loss
>500ml vag birth or
>1000ml C/S
OR
Increased bleeding during
recovery or postpartum
5
STAGE 2
Cumulative blood loss
1500 ml
Continued bleeding
Pulse >120
Decreased BP
STAGE 3
Cumulative blood loss
>1500 ml
OR
Suspicion of DIC
Pulse >140
Decreased BP
Providence Clinical Academy: Obstetrics
2016.07
Stage 1
Cumulative Blood Loss >500ml vag birth>1000ml C/S OR
Increased bleeding during recovery or postpartum

6
Nursing Care:

LIP:

Establish IV access if not present, at
least 18 gauge

Methergine 0.2mg IM if not
hypertensive

Increase Oxytocin and titrate to
uterine tone

If hypertensive give *Hemabate 250mcg
IM or *Misoprostol 800mcg rectally

Continue vigorous fundal massage


Assess and empty bladder

Notify LIP/Charge Nurse
Deferential Diagnosis - rule out
retained products of conception,
laceration, hematoma

Administer uterotonics as ordered

Vital Signs q 5-10 minutes including O2
sat & level of consciousness

Weigh, calculate and record cumulative
blood loss

Administer oxygen to maintain O2 sats
at >95%

Type and Screen (if not already done)

Keep patient warm

Document

Surgeon: (if cesarean birth and still
open)

Inspect for uncontrolled bleeding at all
levels, especially, broad ligament,
posterior uterus, and retained placenta
Providence Clinical Academy: Obstetrics
2016.07
Stage 2
1500 mL cumulative blood loss and continued bleeding
Pulse >120, Decreased BP
Nursing Care:











LIP:

Start a 2nd IV and administer IV fluids
(LR is preferred)
Place Foley with urimeter
Continue assessing frequent vital signs
and blood loss
I&O
Maintain communication with charge
nurse
Assists anesthesia provider
Apply Bair Hugger and SCDs
Administer medications as ordered
Assist Anesthesia as needed
Document






Anesthesia:




7
Continue uterotonic medications
Move to the OR- D/C, tamponade
balloon, uterine packing
Order OB Hemorrhage Panel
Type & Cross for 2 units PRBCs or OB
Hemorrhage Pack (if patient bleeding is
not responding to treatment and
interventions
Interventions follow underlying cause for
bleeding
Laborist
Monitor patient vital signs
Provide pain relief
Begin blood replacement as indicated
Providence Clinical Academy: Obstetrics
2016.07
Stage 3
Cumulative blood loss >1500 OR Pulse >140, Decreased BP

Nursing Care:








Maintains communication with team
members
Administer medications as ordered
Set up cell saver
Assists anesthesia as needed
Monitor cumulative blood loss and
update team
Document
Draw labs
LIP:





Order OB Hemorrhage Pack
Uterotonics
Call for GYN/ONC and/or Adult
Intensivist
Consider uterine artery ligation,
interventional radiology, or
hysterectomy
Anesthesia:




8
Suspicion of DIC
Monitor frequent vital signs and
communicate to team
Arterial blood gases and repeat OB
Hemorrhage Panel
Place central line as needed
Continue to administer meds and blood
products
Providence Clinical Academy: Obstetrics
2016.07
APPLY WHAT YOU LEARNED
Postpartum Hemorrhage Case Study
9
Providence Clinical Academy: Obstetrics
2016.07
Case Study: Background Information







10
34 y.o. G2 P1001, 39 1/7 weeks
Planned, repeat C/S
A Neg/ Rubella Pos/ Hepatitis B Neg/ RPR nonreactive
Uneventful prenatal course
No pertinent medical history
16 g IV placed in left wrist
Cefazolin 2 gms IV pre-op
Providence Clinical Academy: Obstetrics
2016.07
Case Study: Background Information


What would this patient’s
risk factors be for PPH?
Prior C/S (Trauma)
What labs should be
drawn pre-op?
CBC
Type & Screen
Admission Hct 36.9
TySc sent
11
Providence Clinical Academy: Obstetrics
2016.07
Case Study
1533
C/S delivery
150
140
130
120
1536
Oxytocin 20
units in 1 L LR
BP 116/68
110
100
BP 105/52
90
HR 90
80
70
HR 70
60
1500
12
1600
0 mL
Cumulative Blood Loss
1700
1800
1900
2000
2100
Providence Clinical Academy: Obstetrics
2200
2016.07
Case Study
1545- Persistent bleeding
noted on uterine layer,
fundus firm, figure 8 stitch
placed
150
140
130
120
1600 – Admit to
recovery room
110
EBL 1200 ml per
anesthesia, < 1000 ml
per surgeon
BP 107/50
100
90
80
HR 76
70
60
1500
13
1600
1000+ mL
Cumulative Blood Loss
1700
1800
1900
2000
2100
Providence Clinical Academy: Obstetrics
2200
2016.07
Case
Study
1615- Nursing note
“large clot expressed
oozing , fundus boggy
150 firmed with massage “
1630 – Nursing Note
“large clots expressed MD
called to bedside”
140
130
120
1615-1620
Methergine 200 mcg IM
Misoprostol 800 mcg PR
HR 105
110
100
BP 100/48
90
80
1645 Return to the OR
70
60
1500
14
1600
1000+ mL
Cumulative Blood Loss
1700
1800
1900
2000
2100
Providence Clinical Academy: Obstetrics
2200
2016.07
Case Study
1700 D&C, EBL
noted at 500 ml
1715
Hemabate 250 mcg
IM
150
140
130
120
1715
Bakri balloon placed
Active bleeding stopped
1730
T&C for 4 units
CBC, Coags drawn
HR 115
110
100
90
BP 98/50
80
70
60
1500
15
1600
1500+ mL
Cumulative Blood Loss
1700
1800
1900
2000
2100
Providence Clinical Academy: Obstetrics
2200
2016.07
Case Study
150
1745
Bleeding slowed to minimal
HR 140
140
Oxytocin 30 units in 500 mL
130
120
110
BP 95/60
100
90
1840
Hct 32.5
Platelets 129
Fibrinogen 205
80
70
60
Cefazolin 2 gm IV
1500
16
1600
1500+ mL
Cumulative Blood Loss
1700
1800
1900
2000
2100
Providence Clinical Academy: Obstetrics
2200
2016.07
Case Study
HR 150
1945
200 mL noted in Bakri Balloon
Fundus 3-5 cm above umbilicus
Abdomen tender
150
140
1955
OB at bedside
U/S done – shows large clot
130
120
2000
Hct 26.9
Platelets 131
Fibrinogen 151
110
100
90
BP 89/45
80
70
2015
Hct 21 per I-Stat
60
1500
17
1600
1700+ mL
Cumulative Blood Loss
1700
1800
1900
2000
2100
Providence Clinical Academy: Obstetrics
2200
2016.07
Case Study
2015 1 unit PRBCs
150
HR 140
2030
Pt transferred to interventional radiology
“moderate amount of bleeding continues”
140
2045
Midazolam and
Fentanyl for sedation
130
120
110
100
2055
Hemorrhage pack ordered
90
2100 1 unit
PRBCs
2130 1 unit
PRBCs
80
70
60
2140 Bilateral uterine artery embolization.
Hemostatsis achieved. 500 ml blood loss into Bakri Balloon
1500
18
BP 80/39
1600
2200+ mL
Cumulative Blood Loss
1700
1800
1900
2000
2100
Providence Clinical Academy: Obstetrics
2200
2016.07
Case Study
2200
Transferred to recovery
150
140
HR 125
2200
4-pack FFP
130
120
2225
4-pack FFP
110
100
BP 92/64
90
2245
4-pack FFP
80
2250
Cryoprecipitate
70
60
2300
Cryoprecipitate, and 1 unit PRBCs
1500
19
1600
2200+ mL
Cumulative Blood Loss
1700
1800
1900
2000
2100
Providence Clinical Academy: Obstetrics
2200
2016.07
Case Study: Conclusion
The patient remained stable in recovery after the uterine artery embolization
with scant lochia rubra then transferred to ICU after recovery
Labs were the following:
0000
Hct 30.6, WBC 24.9, Platelets 88, Fibrinogen 164
0400
Hct 29.1, WBC 19.1, Platelets 75, Fibrinogen 199
0730
Hct 28.6, WBC 15.9, Platelets 67, Fibrinogen 226
Bakri Balloon removed at noon post-op day #1 with 200 mL blood loss in bag
Total EBL = ???
Pt transferred in stable condition to postpartum at 1500
Discharged to home on post-op day #5
20
Providence Clinical Academy: Obstetrics
2016.07
Which of these common mistakes occurred in
this case?
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
21
Treating postpartum hemorrhage as a diagnosis and not
identifying the cause
Underestimation of blood loss
Inattention to vital sign trends
Delay in intervening surgically if needed
Delay in laboratory assessment
Delay in instituting blood replacement therapy
Delay in moving from “normal delivery” to “life threatening
emergency”
Poor communication between nurse and OB providers on
amount of blood loss, vital signs and other clinical indicators
Lack of communication between OB provider and anesthesia
who is managing blood loss and replacement therapy
Insufficient preoperative preparation for massive hemorrhage
(placenta previa, known or suspected accreta)
Providence Clinical Academy: Obstetrics
2016.07
Case Study Reflection
22

Underestimation of blood loss- it was difficult to
determine cumulative blood loss during this case. The
RN should of weighed blood loss and a cumulative total
should have been noted.

Inattention to vital signs and delay in instituting blood
replacement therapy - the patient was tachycardic an
hypotensive, blood replaced was delayed until laboratory
values reflected the need for blood replacement.
Providence Clinical Academy: Obstetrics
2016.07
Case Study: Stage 0
1533
C/S delivery
150
140
130
120
1536
Oxytocin 20
units in 1 L LR
BP 116/68
110
100
BP 105/52
90
HR 90
80
70
HR 70
60
1500
23
1600
0 mL
Cumulative Blood Loss
1700
1800
1900
2000
2100
Providence Clinical Academy: Obstetrics
2200
2016.07
Case Study: Stage 1
1545- Persistent bleeding
noted on uterine layer,
fundus firm, figure 8 stitch
placed
150
140
130
120
1600 – Admit to
recovery room
110
EBL 1200 ml per
anesthesia, < 1000 ml
per surgeon
BP 107/50
100
90
80
HR 76
70
60
1500
24
1600
1000+ mL
Cumulative Blood Loss
1700
1800
Stage 1:
Greater than 1000 mL blood
loss with stable vital signs
•Exact blood loss unknown as
laps have not been weighed
•Oxytocin
should
be increased
1900
2000
2100
2200
Providence Clinical Academy: Obstetrics
2016.07
Case Study: Stage 2
1615- Nursing note
“large clot expressed
oozing , fundus boggy
150 firmed with massage “
1630 – Nursing Note
“large clots expressed MD
called to bedside”
140
130
120
1615-1620
Methergine 200 mcg IM
Misoprostol 800 mcg PR
HR 105
110
100
BP 100/48
90
80
1645 Return to the OR
70
Stage 2:
Less than 1500 mL blood loss
& continued bleeding &
decreased BP/elevated HR
• Need a 2nd IV
• OB Hemorrhage labs and at
least 2 units of PRBCs should
be ordered
• Increase Oxytocin rate
• Give Hemabate and repeat
all Uterotonics per guidelines
60
1500
25
1600
1000+ mL
Cumulative Blood Loss
1700
1800
1900
2000
2100
Providence Clinical Academy: Obstetrics
2200
2016.07
Case Study: Stage 3
1700 D&C, EBL
noted at 500 ml
1715
Hemabate 250 mcg
IM
150
140
130
120
1715
Bakri balloon placed
Active bleeding stopped
1730
T&C for 4 units
CBC, Coags drawn
HR 115
110
100
90
Stage 3:
Greater than 1500 mL blood
loss
• 2nd IV, labs, and PRBCs
should have already been
ordered
• Hemabate may be repeated
q 15-90 mins x 8
BP 98/50
80
70
60
1500
26
1600
1500+ mL
Cumulative Blood Loss
1700
1800
1900
2000
2100
Providence Clinical Academy: Obstetrics
2200
2016.07
Case Study: Stage 3
150
1745
Bleeding slowed to minimal
HR 140
140
Oxytocin 30 units in 500 mL
130
120
Stage 3:
Greater than 1500 mL blood loss
• Methergine may be repeated q 24 hours x 5 (only given 1x at this
point)
• Hemabate may be repeated q 1590 mins x 8 (only given x1 at this
point)
• OB Hemorrhage blood products
should be ordered
110
BP 95/60
100
90
1840
Hct 32.5
Platelets 129
Fibrinogen 205
80
70
60
Cefazolin 2 gm IV
1500
27
1600
1500+ mL
Cumulative Blood Loss
1700
1800
1900
2000
2100
Providence Clinical Academy: Obstetrics
2200
2016.07
Case Study: Stage 3
HR 150
1945
200 mL noted in Bakri Balloon
Fundus 3-5 cm above umbilicus
Abdomen tender
150
140
1955
OB at bedside
U/S done – shows large clot
130
120
110
100
90
80
70
60
1500
28
2000
Hct 26.9
Platelets 131
Fibrinogen 151
Stage 3:
Greater than 1500 mL blood loss
• Methergine may be repeated q 2-4 hours x 5
(only given 1x at this point)
• Hemabate may be repeated q 15-90 mins x 8
(only given x1 at this point)
• OB Panel to be repeated q 30 mins (this was
done 1 hour ago at this point)
• No blood has yet been transfused at this time
(Type & Cross for 4 units ordered at 1730)
1600
1700+ mL
Cumulative Blood Loss
1700
1800
1900
BP 89/45
2015
Hct 21 per I-Stat
2000
2100
Providence Clinical Academy: Obstetrics
2200
2016.07
Case Study: Stage 3
2015 1 unit PRBCs
150
HR 140
2030
Pt transferred to interventional radiology
“moderate amount of bleeding continues”
140
2045
Midazolam and
Fentanyl for sedation
130
120
110
100
90
80
Stage 3:
• 1st unit of PRBCs given 3
hours after it was ordered
• Still only 1 dose of
Hemabate and Methergine
given at this time
• OB Hem blood products
ordered 5 hours after start
of Stage 3
2055
Hemorrhage pack ordered
2100 1 unit
PRBCs
2130 1 unit
PRBCs
70
60
2140 Bilateral uterine artery embolization.
Hemostatsis achieved. 500 ml blood loss into Bakri Balloon
1500
29
BP 80/39
1600
2200+ mL
Cumulative Blood Loss
1700
1800
1900
2000
2100
Providence Clinical Academy: Obstetrics
2200
2016.07
Case Study: Stage 3
150
140
130
120
2200
Transferred to recovery
Stage 3:
• Still no other uterotonics
administered
• No labs since 2015
•OB Hem Panel to be done q
30 mins in PPH
HR 125
2200
4-pack FFP
2225
4-pack FFP
110
100
BP 92/64
90
2245
4-pack FFP
80
2250
Cryoprecipitate
70
60
2300
Cryoprecipitate, and 1 unit PRBCs
1500
30
1600
2200+ mL
Cumulative Blood Loss
1700
1800
1900
2000
2100
Providence Clinical Academy: Obstetrics
2200
2016.07
What are the possible physiologic reasons for Sarah’s current
condition? (choose all that apply)
a)
Knowledge Check
After C/S delivery Sarah is
transferred to the OB/PACU.
Nausea due to ice chips
b)
Tachycardia related to pain, repositioning, and movement
during transfer from OB/PACU to postpartum
c)
Possible internal bleeding
The 2nd PP check reveals: BP
99/50
Pulse 126
RR 20
Temp 98.2° F (oral)
The abdominal dressing is C, D, &
I
FF @ 2 cm below
Abdomen palpates slightly
distended
Patient complains of slight nausea.
31
Providence Clinical Academy: Obstetrics
2016.07
Nursing interventions should include all of the following EXCEPT?
a)
Request a bedside assessment by the charge nurse
b)
Request a bedside assessment by the physician
c)
Request an order to type and crossmatch the patient
Knowledge Check
At the next assessment:
Sarah’s fundus is difficult to
palpate.
Abd dressing C, D, & I
d)
Administer additional antiemetics
e)
Bolus with IV fluids
BP 88/50 mmHg
Prepare to start second IV line for access
After administration of an
antiemetic, Sarah starts vomiting
and her skin is clammy to touch.
She says she feels weak and cold.
f)
32
Lochia is scant.
Pulse is 130 bpm.
Providence Clinical Academy: Obstetrics
2016.07
What should be the next management plan? (choose all that apply)
a)
Notify anesthesia and immediately transfer to OR
Knowledge Check
b)
Continue to monitor, blood pressure, and pulse oximetry
monitors
Sarah's physician is at the
bedside.
BP 85/30 mmHg
c)
Run IV of LR wide open to increase her fluid volume
d)
Administer 2 units of blood emergently without
verification
There is no new urine output
e)
Order OB Hemorrhage labs
ABD dressing is C,D, & I.
f)
Apply oxygen via non-rebreather face mask
The abdomen is distended and
the uterus cannot be palpated.
P 140 bpm
Lochia is scant.
Sarah now rates her pain at 7.
33
Providence Clinical Academy: Obstetrics
2016.07
What transfusion orders should be given at this time? (choose all that
apply)
a)
Transfuse 4 units of PRBC now and anticipate an order
for 2 additional units
b)
Transfuse 1 unit of PRBC pending lab results
c)
Thaw fresh frozen plasma and give as soon as available
d)
Give 1 unit of pooled platelets
e)
Give recombinant factor VIIa
Knowledge Check
When the surgery starts, the
obstetrician finds Sarah’s
abdomen full of blood.
The LIP found the left uterine
artery is lacerated. The bleeding is
controlled with additional
suturing.
After suctioning, the canister
contains 1500 mL of blood.
Capillary oozing is visible. The lab
results will be available in 5
minutes.
BP 80/42 mmHg
Pulse is 140 bpm.
34
Providence Clinical Academy: Obstetrics
2016.07
Further management of this patient should include? (choose all that
apply)
Knowledge Check
Anticipate that more blood and blood products will be
ordered and administered
Sarah’s active bleeding has
subsided and there is only slight
capillary oozing after the
laparotomy.
b)
Apply warming unit to the patient (warming blankets
such as Bear Hugger®)
Initial PACU lab values include:
Hct 20%
Fibrinogen 60 mg/dL
Platelets 55,000/µL
c)
Strict input and output records
Core temp 96.2°F
BP 104/58 mmHg
Pulse 112 bpm.
d)
Follow PACU protocol
a)
35
Providence Clinical Academy: Obstetrics
2016.07